TY - JOUR
T1 - Pharmaceutical residues in senior residences wastewaters
T2 - High loads, emerging risks
AU - Lacorte, Silvia
AU - Gómez-Canela, Cristian
AU - Calas-Blanchard, Carole
N1 - Funding Information:
Funding: This research was funded by the Interreg SUDOE program funded by FEDER [Innovec’EAU (2016–2019)/Project SOE1/P1/F0173. http://innovec-eau.univ-perp.fr (accessed on 4 July 2021)]. The Ministry of Science and Innovation of Spain under the project PID2019-105732GB-C21 is also acknowledged.
Funding Information:
This research was funded by the Interreg SUDOE program funded by FEDER [Innovec?EAU (2016?2019)/Project SOE1/P1/F0173. http://innovec-eau.univ-perp.fr (accessed on 4 July 2021)]. The Ministry of Science and Innovation of Spain under the project PID2019-105732GB-C21 is also acknowledged.
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/8/2
Y1 - 2021/8/2
N2 - Senior residences are health-care facilities that are socially-accepted for the assistance of elderly people. Since the elderly account for the foremost pharmaceutical-consuming age-group, senior residences become a hot-spot for pharmaceuticals discharge to the sewage grid. The objectives of the present study were to identify the bioactive pharmaceuticals in sewage waters from senior residences and to propose an on-site monitoring strategy for their control. In this study, we have studied the presence of 43 pharmaceuticals highly consumed by the elderly population in six senior residences located in Spain, France and Portugal. Wastewater was sampled directly from the water-chest in each residence during different times of the day throughout one week. Main compounds detected at the high µg L−1 level were analgesic and antipyretic drugs such as acetylsalicylic acid, paracetamol, ibuprofen; antibiotics such as amoxicillin and sulfamethoxazole; compounds for the treatment of neuropathies as gabapentin, trazodone and valsartan; pharmaceuticals for the treatment of diabetes (vildagliptin) and anticancer drugs. The daily loads discharged were estimated and their fate was evaluated. The final objective of this study is to highlight the need to implement at-source waste water treatment procedures in senior residences, which have been identified as a point source pollution of pharmaceuticals.
AB - Senior residences are health-care facilities that are socially-accepted for the assistance of elderly people. Since the elderly account for the foremost pharmaceutical-consuming age-group, senior residences become a hot-spot for pharmaceuticals discharge to the sewage grid. The objectives of the present study were to identify the bioactive pharmaceuticals in sewage waters from senior residences and to propose an on-site monitoring strategy for their control. In this study, we have studied the presence of 43 pharmaceuticals highly consumed by the elderly population in six senior residences located in Spain, France and Portugal. Wastewater was sampled directly from the water-chest in each residence during different times of the day throughout one week. Main compounds detected at the high µg L−1 level were analgesic and antipyretic drugs such as acetylsalicylic acid, paracetamol, ibuprofen; antibiotics such as amoxicillin and sulfamethoxazole; compounds for the treatment of neuropathies as gabapentin, trazodone and valsartan; pharmaceuticals for the treatment of diabetes (vildagliptin) and anticancer drugs. The daily loads discharged were estimated and their fate was evaluated. The final objective of this study is to highlight the need to implement at-source waste water treatment procedures in senior residences, which have been identified as a point source pollution of pharmaceuticals.
KW - Pharmaceuticals
KW - Senior residences
KW - Sewage grid
KW - Wastewater
UR - http://www.scopus.com/inward/record.url?scp=85113578384&partnerID=8YFLogxK
UR - http://hdl.handle.net/20.500.14342/4555
U2 - 10.3390/molecules26165047
DO - 10.3390/molecules26165047
M3 - Article
C2 - 34443636
AN - SCOPUS:85113578384
SN - 1420-3049
VL - 26
JO - Molecules
JF - Molecules
IS - 16
M1 - 5047
ER -